TAMs can originate from both circulating Ly6C+CCR2+ monocytes and resident tissue macrophages (RTMs) close to the tumor, as has been demonstrated in the context of gliomas and pancreatic malignancies (Fig. 1a) [19, 20]. This evidence concerns the gene CCR2 and neoplasm.